New drug shows promise for rare eye disease
NCT ID NCT06388083
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 25 times
Summary
This study tests a drug called tinlarebant in 60 people with Stargardt disease, a genetic condition that causes vision loss. The goal is to see if the drug can slow the growth of damage in the back of the eye and help preserve sight. Participants will receive either the drug or a placebo, and researchers will monitor safety and changes in vision over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STGD1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Belite Study Site
Kobe, Japan
-
Belite Study Site
Kyoto, Japan
-
Belite Study Site
Tokyo, Japan
-
Belite Study Site - US01
Boston, Massachusetts, 02115, United States
-
Belite Study Site - US02
Durham, North Carolina, 27705, United States
-
Belite Study Site - US03
Dallas, Texas, 75231, United States
-
Belite Study Site - US04
Rochester, Minnesota, 55905, United States
-
Belite Study Site - US05
La Jolla, California, 92093, United States
-
Belite Study Site - US06
Miami, Florida, 33136, United States
-
Belite Study Site - US07
Philadelphia, Pennsylvania, 19107, United States
-
Belite Study Site - US08
Phoenix, Arizona, 85020, United States
-
Belite Study Site - US09
San Francisco, California, 94158, United States
-
Belite Study Site - US10
Westbury, New York, 11590, United States
-
Belite Study Site - US11
Edina, Minnesota, 55435, United States
-
Belite Study Site - US12
The Woodlands, Texas, 77384, United States
-
Belite Study Site - US13
Austin, Texas, 78705, United States
-
Belite Study Site - US14
New York, New York, 10032, United States
-
UK01 Belite Study Site
London, United Kingdom
Conditions
Explore the condition pages connected to this study.